Markus Lill

Dr. Lill received his Diploma in Physics from the University of Erlangen-Nürnberg, Germany and his Ph.D. from the Max Planck Institute for Biophysics, Frankfurt, Germany. He completed two years of Postdoctoral training at the Biographics Laboratory 3R in Basel, Switzerland, before being promoted to project leader in ADMET research. In parallel, he was a reader at the Department of Pharmaceutical Sciences of the University of Basel, completing his Habilitation in 2006. In 2006, he started as an Assistant Professor at Purdue University being promoted to tenured Associate Professor in 2012. Between 2014 and 2016 he was repeatedly Visiting Scientist at the German Cancer Research Center in Heidelberg. In 2019 he was appointed Professor for Computational Pharmacy at the Department of Pharmaceutical Sciences, University of Basel.

His research focuses on developing and applying computational drug discovery methods that combine biophysical models and simulations with modern deep neural network approaches. Projects in this context range from target-specific de novo design, high-content screening, one-shot generation of protein and protein-ligand configurations, efficient docking, to the prediction of binding affinities.